| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.462 | 1.496 | 7.248 | 5.838 | 6.024 | 3.277 | 2.983 | 14.453 | 17.063 | 16.813 |
| Total Income - EUR | 2.220 | 1.636 | 7.320 | 6.089 | 6.175 | 3.294 | 2.983 | 14.453 | 17.058 | 16.813 |
| Total Expenses - EUR | 7.550 | 8.552 | 2.169 | 6.497 | 10.943 | 7.272 | 7.244 | 11.177 | 14.319 | 21.567 |
| Gross Profit/Loss - EUR | -5.330 | -6.916 | 5.151 | -408 | -4.768 | -3.978 | -4.261 | 3.276 | 2.740 | -4.753 |
| Net Profit/Loss - EUR | -5.384 | -6.962 | 49 | -584 | -4.950 | -4.077 | -4.350 | 2.843 | 2.740 | -4.798 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Mateoconsult Lifemed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 52.886 | 51.207 | 49.220 | 47.216 | 71.383 | 69.122 | 66.816 | 64.345 | 61.760 | 60.983 |
| Current Assets | 2.306 | 2.297 | 2.370 | 2.247 | 2.697 | 2.856 | 2.489 | 3.942 | 5.551 | 1.035 |
| Inventories | 1.855 | 1.836 | 1.805 | 1.772 | 1.738 | 1.906 | 1.864 | 2.205 | 2.570 | 0 |
| Receivables | 286 | 405 | 518 | 0 | 421 | 413 | 404 | 406 | 729 | 725 |
| Cash | 165 | 57 | 47 | 475 | 537 | 536 | 221 | 1.331 | 2.253 | 310 |
| Shareholders Funds | -41.466 | -48.005 | -47.144 | -46.863 | -24.943 | -28.547 | -32.264 | -29.521 | -26.692 | -31.341 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 96.659 | 101.510 | 98.734 | 96.326 | 99.023 | 100.525 | 101.569 | 97.807 | 94.003 | 93.359 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mateoconsult Lifemed Srl